These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3933404

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M, Nogami K, Matsumoto T, Soeda T, Suzuki T, Hattori K, Shima M.
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [Abstract] [Full Text] [Related]

  • 4. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW, Trabold NC.
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of four monoclonal antibodies to factor VIII coagulant protein and their use in immunopurification of factor VIII.
    Croissant MP, van de Pol H, Lee HH, Allain JP.
    Thromb Haemost; 1986 Dec 15; 56(3):271-6. PubMed ID: 2436329
    [Abstract] [Full Text] [Related]

  • 7. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE, Thuy LP, Carton CL, Hougie C.
    J Lab Clin Med; 1983 May 15; 101(5):793-805. PubMed ID: 6403639
    [Abstract] [Full Text] [Related]

  • 8. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ, Pemberton S, Acquila M, Mori PG, Tuddenham EG, O'Brien DP.
    Thromb Haemost; 1994 Apr 15; 71(4):428-33. PubMed ID: 8052958
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of a form of bovine factor VIII which does not aggregate human platelets.
    Kirby EP.
    Thromb Haemost; 1981 Aug 28; 46(2):479-84. PubMed ID: 6795738
    [Abstract] [Full Text] [Related]

  • 12. A2 domain of human recombinant-derived factor VIII is required for procoagulant activity but not for thrombin cleavage.
    Pittman DD, Millenson M, Marquette K, Bauer K, Kaufman RJ.
    Blood; 1992 Jan 15; 79(2):389-97. PubMed ID: 1730084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure and function of factor VIII procoagulant protein.
    Fulcher CA, Zimmerman TS.
    Prog Clin Biol Res; 1984 Jan 15; 150():57-71. PubMed ID: 6431442
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X.
    Khrenov AV, Ananyeva NM, Saenko EL.
    Blood Coagul Fibrinolysis; 2006 Jul 15; 17(5):379-88. PubMed ID: 16788314
    [Abstract] [Full Text] [Related]

  • 17. Binding to phospholipid protects factor VIII from inactivation by human antibodies.
    Barrowcliffe TW, Kemball-Cook G, Gray E.
    J Lab Clin Med; 1983 Jan 15; 101(1):34-43. PubMed ID: 6401316
    [Abstract] [Full Text] [Related]

  • 18. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay.
    Kopitsky RG, Switzer ME, McKee PA.
    Thromb Haemost; 1982 Apr 30; 47(2):145-9. PubMed ID: 6213066
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain.
    Hill-Eubanks DC, Lollar P.
    J Biol Chem; 1990 Oct 15; 265(29):17854-8. PubMed ID: 2120219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.